Advertisement

Topics

Blade Therapeutics Expands Leadership Team as Company Advances R&D Pipeline Addressing Fibrotic Diseases

08:00 EDT 20 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Dr. Ramona Doyle appointed as Chief Medical Officer, Dr. Prabha Ibrahim becomes Chief Technology Officer Blade anticipates commencement of IND-enabling studies for its lead development program by year-end 2017 ...

Other Sources for this Article

Blade Therapeutics
Wendye Robbins, M.D., President and CEO
wrobbins@blademed.com
or
Felix Karim, Ph.D., Executive Vice President, Business Development
650-278-4291

NEXT ARTICLE

More From BioPortfolio on "Blade Therapeutics Expands Leadership Team as Company Advances R&D Pipeline Addressing Fibrotic Diseases"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...